From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：4
|
作者：
Thatcher, Thomas H. [1 ]
Peters-Golden, Marc [2 ]
机构：
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期
关键词：
THROMBOXANE A(2); RECEPTOR;
D O I：
10.1164/rccm.202205-0914ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530 / 532
页数：4
相关论文
共 50 条
  • [1] F2-isoprostanes and hepatic fibrosis
    Comporti, M
    Arezzini, B
    Signorini, C
    Sgherri, C
    Vecchio, D
    Monaco, B
    Gardi, C
    SFRR: PROCEEDINGS OF THE XII BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, 2004, : 267 - 272
  • [2] Quantification of F2-isoprostanes as a biomarker of oxidative stress
    Milne, Ginger L.
    Sanchez, Stephanie C.
    Musiek, Erik S.
    Morrow, Jason D.
    NATURE PROTOCOLS, 2007, 2 (01) : 221 - 226
  • [3] Quantification of F2-isoprostanes as a biomarker of oxidative stress
    Ginger L Milne
    Stephanie C Sanchez
    Erik S Musiek
    Jason D Morrow
    Nature Protocols, 2007, 2 : 221 - 226
  • [4] F2-Isoprostanes as a Biomarker of Oxidative Stress in the Mouse Bladder
    Clayton, Douglass B.
    Stephany, Heidi A.
    Ching, Christina B.
    Rahman, Shareena A.
    Tanaka, Stacy T.
    Thomas, John C.
    Pope, John C.
    Adams, Mark C.
    Brock, John W., III
    Clark, Peter E.
    Hayward, Simon W.
    Matusik, Robert J.
    Milne, Ginger L.
    JOURNAL OF UROLOGY, 2014, 191 (05): : 1597 - 1601
  • [5] F2-isoprostanes and the liver
    Guha, IN
    Moore, K
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2003, 72 (1-2) : 73 - 84
  • [6] F2-isoprostanes and the kidney
    Salahudeen, AK
    Reckelhoff, JF
    Morrow, JD
    Roberts, LJ
    DRUG NEWS & PERSPECTIVES, 1998, 11 (05) : 287 - 290
  • [7] Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
    Il'yasova, Dora
    Spasojevic, Ivan
    Base, Karel
    Zhang, Haoyue
    Wang, Frances
    Young, Sarah P.
    Millington, David S.
    D'Agostino, Ralph B., Jr.
    Wagenknecht, Lynne E.
    DIABETES CARE, 2012, 35 (01) : 173 - 174
  • [8] F2-Isoprostanes An Emerging Pulmonary Arterial Hypertension Biomarker and Potential Link to the Metabolic Theory of Pulmonary Arterial Hypertension?
    Dromparis, Peter
    Michelakis, Evangelos D.
    CHEST, 2012, 142 (04) : 816 - 820
  • [9] EFFECT OF VITAMIN E AND SELENIUM ON F2-ISOPROSTANES, AN OXIDATIVE STRESS BIOMARKER
    Guertin, K. A.
    Grant, R. K.
    Kristal, A. R.
    Arnold, K. B.
    Hartline, J. A.
    Goodman, P. J.
    Tangen, C. M.
    Minasian, L. M.
    Lippman, S. M.
    Klein, E.
    Cassano, P. A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S324 - S324
  • [10] F2-isoprostanes can mediate bleomycin-induced lung fibrosis
    Arezzini, Beatrice
    Vecchio, Daniela
    Signorini, Cinzia
    Stringa, Blerta
    Gardi, Concetta
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 115 : 1 - 9
12345